讨论
莫芒旎2022-08-14 09:00
$美鼎生物(VIVO)$ 收购什么时候完成？瞎买了230120的35看涨期权，是不是打水漂了？![[哭泣]](https://js.xueqiu.com/ugc/images/face/emoji_09_cry.png?v=1 "[哭泣]"){kind=small}
查看全文
简介：Meridian Bioscience, Inc.于1976年在俄亥俄州成立。Meridian是一家完全整合的生命科学公司，主要业务是：（i）开发、制造、销售和分销诊断检测试剂盒，主要用于某些胃肠道和呼吸道传染病以及血铅水平升高；以及（ii）制造和分销体抗原、抗体，体外诊断（“IVD”）制造商和研究人员在人类、动物、植物和环境应用的免疫学和分子试验中使用的PCR/qPCR试剂、核苷酸和生物搜索试剂。
| 今开： | 昨收：33.97 |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值：1494957161 |
莫芒旎2022-08-14 09:00
$美鼎生物(VIVO)$ 收购什么时候完成？瞎买了230120的35看涨期权，是不是打水漂了？查看全文
用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-010390 Act: 34 Size: 93 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022599 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022584 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022588 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022594 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022578 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022579 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022572 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022573 Act: 33 Size: 35 KB 网页链接
$美鼎生物(VIVO)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-022562 Act: 33 Size: 35 KB 网页链接